Industry Focus

Geron shares tumbled after J&J jilted them and Omeros  shares fell sharply following a clinical-trial update. Should you avoid these stocks, or are they bargain bin stocks worth buying? GERN OMER INCY

Direct download: 20181003_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST

1